Transcriptional regulation of HMG-CoA synthase and HMG-CoA reductase genes by human ACBP

Cellular Physiology and Biochemistry

Volumn 22, Issue 5-6, 2008, Pages 515-524

  Vock, Christina ^a   Döring, Frank ^a   Nitz, Inke ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

Cholesterol; Gene regulation; HNF 4 ; Promoter analysis

Indexed keywords

DIAZEPAM BINDING INHIBITOR; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; HYDROXYMETHYLGLUTARYL COENZYME A SYNTHASE;

ARTICLE; CELL CULTURE; CHOLESTEROL SYNTHESIS; COMPARATIVE STUDY; GENE; GENETIC TRANSFECTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; TRANSCRIPTION REGULATION;

EID: 57649200113     PISSN: 10158987     EISSN: None     Source Type: Journal    
DOI: 10.1159/000185525     Document Type: Article

References (47)

1. Guidotti A, Forchetti CM, Corda MG, Konkel D, Bennett CD, Costa E: Isolation, characterization, and purification to homogeneity of an endogenous polypeptide with agonistic action on benzodiazepine receptors. Proc Natl Acad Sci U S A 1983;80:3531-3535.
2. Kragelund BB, Knudsen J, Poulsen FM: Acyl-coenzyme A binding protein (ACBP). Biochimica et Biophysica Acta-Molecular and Cell Biology of Lipids 1999;1441:150-161.
3. Chen ZW, Agerberth B, Gell K, Andersson M, Mutt V, Ostenson CG, Efendic S, Barrossoderling J, Persson B, Jornvall H: Isolation ad characterization of porcine diazepam-binding inhibitor, apolypeptide not only of cerebral occurrence but also common in intestinal tissues and with effects on regulation of insulin resistance. European Journal of Biochemistry 1988;174:239-245.
4. Borboni P, Condorelli L, De Stefanis P, Sesti G, Lauro R: Modulation of insulin secretion by diazepam binding inhibitor and its processing products. Neuropharmacology 1991;30:1399-1403.
5. Garnier M, Boujrad N, Oke BO, Brown AS, Riond J, Ferrara P, Shoyab M, Suarez-Quian CA, Papadopoulos V: Diazepam binding inhibitor is a paracrine/autocrine regulator of Leydig cell proliferation and steroidogenesis: action via peripheraltype benzodiazepine receptor and independent mechanisms. Endocrinology 1993;132:444-458.
6. Taupin V, Gogusev J, Descamps-Latscha B, Zavala F: Modulation of tumor necrosis factor-alpha, interleukin-1 beta, interleukin-6, interleukin-8, and granulocyte/macrophage colony-stimulating factor expression in human monocytes by an endogenous anxiogenic benzodiazepine ligand, triakontatetraneuropeptide: evidence for a role of prostaglandins. Mol Pharmacol 1993;43:64-69.
7. Taupin V, Herbelin A, Descamps-Latscha B, Zavala F: Endogenous anxiogenic peptide, ODN-diazepam-binding inhibitor, and benzodiazepines enhance the production of interleukin-1 and tumor necrosis factor by human monocytes. Lymphokine Cytokine Res 1991;10:7-13.
8. Agerberth B, Boman A, Andersson M, Jornvall H, Mutt V, Boman HG: Isolation of three antibacterial peptides from pig intestine: gastric inhibitory polypeptide (7-42), diazepam-binding inhibitor (32-86) and a novel factor, peptide 3910. Eur J Biochem 1993;216:623-629.
9. Herzig KH, Schon I, Tatemoto K, Ohe Y, Li Y, Folsch UR, Owyang C: Diazepam binding inhibitor is a potent cholecystokinin releasing peptide in the intestine. Proc Natl Acad Sci U S A 1996;93:7927-7932.
10. Boujrad N, Hudson JR, Jr., Papadopoulos V: Inhibition of hormone-stimulated steroidogenesis in cultured Leydig tumor cells by a cholesterol-linked phosphorothioate oligodeoxynucleotide antisense to diazepam-binding inhibitor. Proc Natl Acad Sci U S A 1993;90:5728-5731.
11. Papadopoulos V, Brown AS: Role of the peripheral-type benzodiazepine receptor and the polypeptide diazepam binding inhibitor in steroidogenesis. J Steroid Biochem Mol Biol 1995;53:103-110.
12. Besman MJ, Yanagibashi K, Lee TD, Kawamura M, Hall PF, Shively JE: Identification of des-(Gly-Ile)-endozepine as an effector of corticotropin-dependent adrenal steroidogenesis: stimulation of cholesterol delivery is mediated by the peripheral benzodiazepine receptor. Proc Natl Acad Sci U S A 1989;86:4897-4901.
13. Knudsen J, Hojrup P, Hansen HO, Hansen HF, Roepstorff P: Acyl-CoA-binding protein in the rat. Purification, binding characteristics, tissue concentrations and amino acid sequence. Biochem J 1989;262:513-519.
14. Mogensen IB, Schulenberg H, Hansen HO, Spener F, Knudsen J: A novel acyl-CoA-binding protein from bovine liver. Effect on fatty acid synthesis. Biochem J 1987;241:189-192.
15. Mikkelsen J, Knudsen J: Acyl-CoA-binding protein from cow. Binding characteristics and cellular and tissue distribution. Biochem J 1987;248:709-714.
16. Rasmussen JT, Rosendal J, Knudsen J: Interaction of acyl-CoA-binding protein (ACBP) on processes for which acyl-CoA is a substrate, product or inhibitor. Biochemical Journal 1993;292:907-913.
17. Mandrup S, Jepsen R, Skott H, Rosendal J, Hojrup P, Kristiansen K, Knudsen J: Effect of heterologous expression of acyl-CoA-binding protein on acyl-CoA level and composition in yeast. Biochemical Journal 1993;290:369-374.
18. Chao H, Martin GG, Russell WK, Waghela SD, Russell DH, Schroeder F, Kier AB: Membrane charge and curvature determine interaction with acyl-CoA binding protein (ACBP) and fatty acyl-CoA targeting. Biochemistry 2002;41:10540-10553.
19. Rasmussen JT, Faergeman NJ, Kristiansen K, Knudsen J: Acyl-CoA binding protein (ACBP) can mediate intermembrane acyl-CoA transport and donate acyl-CoA for beta-oxidation and glycerolipid synthesis. Biochemical Journal 1994;299:165-170.
20. Jolly CA, Wilton DC, Schroeder F: Microsomal fatty acyl-CoA transacylation and hydrolysis: fatty acyl-CoA species dependent modulation by liver fatty acyl-CoA binding proteins. Biochim Biophys Acta 2000;1483:185-197.
21. Gossett RE, Edmondson RD, Jolly CA, Cho TH, Russell DH, Knudsen J, Kier AB, Schroeder F: Structure and function of normal and transformed murine acyl-CoA binding proteins. Arch Biochem Biophys 1998;350:201-213.
22. Abo-Hashema KAH, Cake MH, Lukas MA, Knudsen J: The interaction of acyl-CoA with acyl-CoA binding protein and carnitine palmitoyltransferase I. International Journal of Biochemistry & Cell Biology 2001;33:807-815.
23. Faergeman NJ, Knudsen J: Role of long-chain fatty acyl-CoA esters in the regulation of metabolism and in cell signalling. Biochemical Journal 1997;323:1-12.
24. DiRusso CC, Heimert TL, Metzger AK: Characterization of FadR, a global transcriptional regulator of fatty acid metabolism in Escherichia coli. Interaction with the fadB promoter is prevented by long chain fatty acyl coenzyme A. J Biol Chem 1992;267:8685-8691.
25. Hertz R, Magenheim J, Berman I, Bar-Tana J: Fatty acyl-CoA thioesters are ligands of hepatic nuclear factor-4alpha. Nature 1998;392:512-516.
26. Elholm M, Dam I, Jorgensen C, Krogsdam AM, Holst D, Kratchmarova I, Gottlicher M, Gustafsson JA, Berge R, Flatmark T, Knudsen J, Mandrup S, Kristiansen K: Acyl-CoA esters antagonize the effects of ligands on peroxisome proliferator-activated receptor alpha conformation, DNA binding, and interaction with Co-factors. J Biol Chem 2001;276:21410-21416.
27. Feddersen S, Neergaard TB, Knudsen J, Faergeman NJ: Transcriptional regulation of phospholipid biosynthesis is linked to fatty acid metabolism by an acyl-CoA binding protein dependent mechanism in Saccharomyces cerevisiae. Biochem J 2007;407:219-230
28. Petrescu AD, Payne HR, Boedecker A, Chao H, Hertz R, Bar-Tana J, Schroeder F, Kier AB: Physical and functional interaction of acyl-CoA-binding protein with hepatocyte nuclear factor-4 alpha. Journal of Biological Chemistry 2003;278:51813-51824.
29. Yanagibashi K, Ohno Y, Kawamura M, Hall PF: The regulation of intracellular transport of cholesterol in bovine adrenal cells: purification of a novel protein. Endocrinology 1988;123:2075-2082.
30. Klapper M, Bohme M, Nitz I, Doring F: The human intestinal fatty acid binding protein (hFABP2) gene is regulated by HNF-4alpha. Biochem Biophys Res Commun 2007;356:147-152.
31. Butchbach ME, Tian G, Guo H, Lin CL: Association of excitatory amino acid transporters, especially EAAT2, with cholesterol-rich lipid raft microdomains: importance for excitatory amino acid transporter localization and function. J Biol Chem 2004;279:34388-34396.
32. Hayhurst GP, Lee YH, Lambert G, Ward JM, Gonzalez FJ: Hepatocyte nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis. Mol Cell Biol 2001;21:1393-1403.
33. Olsen L, Bressendorff S, Troelsen JT, Olsen J: Differentiation-dependent activation of the human intestinal alkaline phosphatase promoter by HNF-4 in intestinal cells. Am J Physiol Gastrointest Liver Physiol 2005;289:G220-226.
34. Lacapere JJ, Papadopoulos V: Peripheral-type benzodiazepine receptor: structure and function of a cholesterol-binding protein in steroid and bile acid biosynthesis. Steroids 2003;68:569-585.
35. Oikari S, Ahtialansaari T, Heinonen MV, Mauriala T, Auriola S, Kiehne K, Folsch UR, Janne J, Alhonen L, Herzig KH: Downregulation of PPARs and SREBP by acyl-CoA-binding protein overexpression in transgenic rats. Pflugers Arch 2008;456:369-377.
36. Dolt KS, Karar J, Mishra MK, Salim J, Kumar R, Grover SK, Qadar Pasha MA: Transcriptional downregulation of sterol metabolism genes in murine liver exposed to acute hypobaric hypoxia. Biochem Biophys Res Commun 2007;354:148-153.
37. Brown MS, Goldstein JL: Multivalent feedback regulation of HMG CoA reductase, a control mechanism coordinating isoprenoid synthesis and cell growth. J Lipid Res 1980;21:505-517.
38. Goldstein JL, Brown MS: Regulation of the mevalonate pathway. Nature 1990;343:425-430.
39. Nakanishi M, Goldstein JL, Brown MS: Multivalent control of 3-hydroxy-3-methylglutaryl coenzyme A reductase. Mevalonate-derived product inhibits translation of mRNA and accelerates degradation of enzyme. J Biol Chem 1988;263:8929-8937.
40. Misawa K, Horiba T, Arimura N, Hirano Y, Inoue J, Emoto N, Shimano H, Shimizu M, Sato R: Sterol regulatory element-binding protein-2 interacts with hepatocyte nuclear factor-4 to enhance sterol isomerase gene expression in hepatocytes. J Biol Chem 2003;278:36176-36182.
41. Inoue J, Sato R, Maeda M: Multiple DNA elements for sterol regulatory element-binding protein and NF-Y are responsible for sterol-regulated transcription of the genes for human 3-hydroxy-3-methylglutaryl coenzyme A synthase and squalene synthase. J Biochem 1998;123:1191-1198.
42. Dooley KA, Millinder S, Osborne TF: Sterol regulation of 3-hydroxy-3-methylglutaryl-coenzyme A synthase gene through a direct interaction between sterol regulatory element binding protein and the trimeric CCAAT-binding factor/ nuclear factor Y. J Biol Chem 1998;273:1349-1356.
43. Knudsen J, Faergeman NJ, Skott H, Hummel R, Borsting C, Rose TM, Andersen JS, Hojrup P, Roepstorff P, Kristiansen K: Yeast acyl-CoA-binding protein: acyl-CoA-binding affinity and effect on intracellular acyl-CoA pool size. Biochem J 1994;302 (Pt 2):479-485.
44. Huang H, Atshaves BP, Frolov A, Kier AB, Schroeder F: Acyl-coenzyme A binding protein expression alters liver fatty acyl-coenzyme A metabolism. Biochemistry 2005;44:10282-10297.
45. Choi JY, Stukey J, Hwang SY, Martin CE: Regulatory elements that control transcription activation and unsaturated fatty acid-mediated repression of the Saccharomyces cerevisiae OLE1 gene. J Biol Chem 1996;271:3581-3589.
46. Kamiryo T, Parthasarathy S, Numa S: Evidence that acyl coenzyme A synthetase activity is required for repression of yeast acetyl coenzyme A carboxylase by exogenous fatty acids. Proc Natl Acad Sci U S A 1976;73:386-390.
47. Cheskis B, Freedman LP: Ligand modulates the conversion of DNA-bound vitamin D3 receptor (VDR) homodimers into VDR-retinoid X receptor heterodimers. Mol Cell Biol 1994;14:3329-3338.